Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02284399 · ClinicalTrials.gov registry record
National Prevalence and Impact of Noninvasive Prenatal Testing
A clinical trial, sponsored by Obstetrix Medical Group.
- Completed
- Registry status
- 4,488
- Enrollment target
NCT02284399: Completed study, sponsored by Obstetrix Medical Group.
NCT02284399 is a clinical trial that has completed, run by Obstetrix Medical Group. The registered enrollment target is 4,488 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02284399 has completed, sponsored by Obstetrix Medical Group.
- COMPLETED
- Registry status
- 4,488 participants
- Enrollment target
Study Summary
Information on pregnant women undergoing non-invasive prenatal testing (NIPT) at one of the Obstetrix Medical Groups Outpatient Centers between January 2012 and June 2014 will be retrospectively gathered and an analysis of the impact and prevalence of NIPT. This will be compared to a control group of pregnant women in those same practices undergoing prenatal testing during the months of January 2010-July 2010.
Primary Outcome
Total Number of patient undergoing invasive diagnostic testing for fetal karyotype (IDTFK) before (control group = Jan - July 2010) and after (test group=Jan 2012-June 2014) NIPT testing came to market
Interventions
- OTHER non-invasive prenatal testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,488 participants |
| Start Date | 2014-01 |
| Est. Completion | 2016-12-01 |
What the finished NCT02284399 record still lists
NCT02284399 is an observational study that tracks outcomes without assigning an intervention. Its 4,488 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which non-invasive prenatal testing is the first listed.
NCT02284399 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02284399 about?
NCT02284399 is a clinical study titled "National Prevalence and Impact of Noninvasive Prenatal Testing". Information on pregnant women undergoing non-invasive prenatal testing (NIPT) at one of the Obstetrix Medical Groups Outpatient Centers between January 2012 and June 2014 will be retrospectively gathered and an analysis of the impact and prevalence of NIPT. This will be compared to a control group o...
What is the current status of trial NCT02284399?
This trial is currently completed. The enrollment target is 4,488 participants. The study started on 2014-01. Estimated completion is 2016-12-01.
What interventions are being tested in trial NCT02284399?
The interventions under investigation include: non-invasive prenatal testing (OTHER).
Who is sponsoring clinical trial NCT02284399?
This trial is sponsored by Obstetrix Medical Group, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06252753 · 4,490 participants
Observational Study Protocol: LIVER-R
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
- NCT06588452 · 4,500 participants
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
- NCT07165028 · 4,500 participants · Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia